Clinical Trials on Post Transplant Diabetes Mellitus in Germany

Total 1173 results

Insuline Medical Ltd.
Forschungsinstitut der Diabetes Akademie Mergentheim

Completed

The InsuPad in Daily Life Study - Effect of Local Heating on Postprandial Glucose Excursions Using the InsuPad Device

Type 1 Diabetes Mellitus With Diabetic Neuralgia

Germany
i-Health, Inc.

Completed

Impact of Oral Probiotic Blend on Pregnancy Outcome

Gestational Diabetes Mellitus in Pregnancy

Germany
Jena University Hospital

Active, not recruiting

Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy (MuKiLOG)

Diabetes, Gestational | Pregnancy Diabetic

Germany
Astellas Pharma Europe B.V.

Completed

A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety (MOBILE)

Neuropathic Pain | Post-Herpetic Neuralgia (PHN) | Painful Diabetic Peripheral Neuropathy (PDPN)

Czechia, Germany, Poland, United Kingdom
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia

Painful Diabetic Neuropathy and Post Herpetic Neuralgia

Germany
Insuline Medical Ltd.

Completed

Testing the Effect of the InsuPad Device in Daily Life Conditions

Diabetes Mellitus Type 2 | Diabetics Mellitus Type 1

Germany
Hannover Medical School

Terminated

Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema

Diabetes Mellitus, Type II

Germany
Jena University Hospital

Recruiting

Treatment Satisfaction and Treatment Adherence of Diabetic Women Through the Use of FGM (Flash)

Gestational Diabetes | Gestational Diabetes Mellitus in Pregnancy

Germany
Technische Universität Dresden

Completed

Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy

Type 2 Diabetes | Overt Diabetic Nephropathy

Germany
Universität Duisburg-Essen

Completed

Complementary and Integrative Therapy for Diabetic Neuropathy (CIT-DN)

Diabetes Mellitus, Type 2 | Diabetic Neuropathy

Germany
Sarah Appel

Active, not recruiting

Cologne Placenta Cohort (CPC)

Gestational Diabetes Mellitus in Pregnancy | Obesity, Maternal

Germany
GWT-TUD GmbH

Terminated

Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia (August-1)

Diabetic Foot | Type 2 Diabetes Mellitus | Critical Limb Ischemia

Germany
Heinrich-Heine University, Duesseldorf

Recruiting

Mitochondrial Substrate Utilization in the Diabetic Human Heart

Heart Failure | Mitochondrial Diseases | Insulin Resistance | Diabetic Cardiomyopathies | Type2diabetes

Germany
Prof. Dr. Thomas Forst

Completed

Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

Type2 Diabetes Mellitus

Germany
Sanofi

Completed

Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

Germany
Sanofi

Completed

A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes (ELDERLY-T)

Type 2 Diabetes Mellitus (T2DM)

Germany
RWTH Aachen University
Boehringer Ingelheim

Completed

Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 Diabetes (EMPA)

Diabetes Mellitus Type 2 (T2DM)

Germany
Kinderkrankenhaus auf der Bult

Terminated

Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D) (Dapa-Stress)

Type 1 Diabetes | Diabetic Ketoacidosis

Germany
German Diabetes Center
Heinrich-Heine University, Duesseldorf

Completed

Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes

Obesity | Non-insulin-dependent Diabetes Mellitus

Germany
RSP Systems A/S

Completed

Non-invasive Glucose Measurement With Raman Technology in Patients With Type 1 and Type 2 Diabetes

Diabete Mellitus | Medical Device

Germany
Johann Wolfgang Goethe University Hospital

Completed

Safety and Feasibility Study of Autologous Progenitor Cell Transplantation in Diabetic Neuropathy

Diabetic Neuropathies

Germany
Hoffmann-La Roche
Roche Diagnostics

Completed

A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Diabetes Mellitus Type 2, Diabetes Mellitus Type 1

Germany
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 Diabetes

Diabetes | Type 2 Diabetes Mellitus

Germany
Institut National de la Santé Et de la Recherche...

Recruiting

CARdiomyopathy in Type 2 DIAbetes Mellitus (CARDIATEAM)

Cardiomyopathy, Diabetic

France, Germany, Spain, Netherlands, United Kingdom
Profil Institut für Stoffwechselforschung GmbH

Completed

Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus (DLW)

Diabetes

Germany
West German Center of Diabetes and Health
German Institute for Telemedicine and Health Promotion

Completed

Diabetes Coaching Study (DCS)

Type 2 Diabetes Mellitus

Germany
Diabetes Schwerpunktpraxis
Woerwag Pharma GmbH & Co. KG

Unknown

Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)

Diabetic Neuropathies

Germany
CellMed AG, a subsidiary of BTG plc.

Completed

Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes

Type II Diabetes Mellitus

Germany
AstraZeneca
Parexel

Completed

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)

Germany
Sanofi

Completed

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Type1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
Diamontech AG
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Recruiting

Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry

Healthy | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 1

Germany
RWTH Aachen University

Terminated

Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus (Diast Dysfkt)

Diabetes Mellitus Type 2 (T2DM) | Left Ventricular Diastolic Dysfunction

Germany
Munich Municipal Hospital
Novo Nordisk A/S

Unknown

Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
West German Center of Diabetes and Health

Recruiting

AI Screening for Diabetic Retinopathy (AimdR)

Diabetes Mellitus

Germany
KeyBioscience AG
Eli Lilly and Company; Profil Institut für Stoffwechselforschung GmbH; Nordic...

Terminated

A Clinical Study to Evaluate the Safety, Tolerability, PK, PD, and Efficacy of KBP-089 in Patients With T2DM

Type II Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device (GoBolus)

Diabetes | Diabetes Mellitus, Type 1 Diabetes

Germany
Adocia

Completed

A Trial to Investigate the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
West German Center of Diabetes and Health
Novartis Pharmaceuticals; Nintendo of Europe GmbH

Completed

Lifestyle Intervention With an Interactive Video Game for Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Germany
Biocon Limited
Juvenile Diabetes Research Foundation; Profil Institut für Stoffwechselforschung...

Terminated

Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil

Type 1 Diabetes Mellitus (T1DM)

Germany
Paracelsus Harz Clinic Bad Suderode.

Completed

Study of Physical Therapy in Patients With Diabetic Polyneuropathy

Diabetic Polyneuropathy

Germany
Benno Brinkhaus
Karl and Veronica Carstens Foundation

Completed

ACUpuncture in Diabetic Peripheral Neuropathy (ACUDPN)

Diabetic Neuropathy

Germany
University Hospital Tuebingen

Withdrawn

Dapagliflozin Effect on Erythropoiesis and Physical Fitness

Type 2 Diabetes Mellitus (T2DM)

Germany
Helmholtz Zentrum München

Recruiting

Fr1da-/Fr1da-Plus-Study in Bavaria: Early Detection for Early Care of Type 1 Diabetes (Fr1da-Plus)

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Compare Post Prandial Blood Glucose Control of BioChaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

Germany
ikfe-CRO GmbH
IKFE Institute for Clinical Research and Development

Unknown

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use

Insulin-requiring Type 2 Diabetes Mellitus

Germany
West German Center of Diabetes and Health
Almased Wellness GmbH

Completed

Metabolic Activation With Protein-rich Formula Diet (AVS)

Type 2 Diabetes Mellitus

Germany
Saniona
Profil Institut für Stoffwechselforschung GmbH

Completed

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
Hannover Medical School
Boehringer Ingelheim

Terminated

SGLT2 Inhibition and Left Ventricular Mass (EMPATROPHY)

Diabetes Mellitus Type 2

Germany

Clinical Trials on Post Transplant Diabetes Mellitus in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations